Login

Username

Password



Not a member yet?
Click here to register.

Forgotten your password?
Request a new one here.

HONcode

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trust worthy health information:
verify here.


Search only trustworthy HONcode health websites:

Affiliations

REACTION is affilliated with these programs and organisations:

REACTION is delivering better and more efficient healthcare services in Europe, thus supporting the Commissions activities in ICT for Health: eHealth.



The REACTION platform allows for the creation of inclusive applications with accessibility for all. The project supports the Commissions campaign: eInclusion - be part of it!



We Fight Spam

Facts



The REACTION project is a 4-year project started in 2010. It is partly funded by the European Commission under the 7th Framework Programme in the area of Personal Health Systems under Grant Agreement no. 248590

 Impressum   Privacy

Events

<< September 2014 >>
Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

No events.


Newsletter


Registered Members Only

Previous Newsletters


Read previous issues of our newsletter here:

April 2014
August 2013
June 2012
August 2011
April 2011
November 2010

Share this

Bookmark and Share

eHealth at Facebook

Join the discussion on EC eHealth at Facebook!

Research award for the GlucoTab

The GlucoTab won in the category 'commercial applications' for 'Human-Technology-Interface': Read more. The prize was a certificate and 7000 euroes.

The GlucoTab system was developed in REACTION as a workflow and insulin dosing support system for glycaemic management of hospitalised patients with diabetes.

It implements a novel, mobile, tablet-based workflow support system for nurses and physicians at the ward which includes a validated basal/bolus insulin titration protocol (REACTION algorithm) to provide decision support for daily glucose management of patients with diabetes.

In REACTION the GlucoTab system was validated in two clinical trials involving a total of 129 patients. Results show a decrease of the mean blood glucose, no increase of hypoglycaemic events and a high user acceptance. The GlucoTab system was CE marked in November 2013 and can now be used in a clinical routine.